Skip to content
  • Spain
  • United Kingdom
  • Europe
  • United States
  • Japan
  • The Middle East
  • Brazil
  • Italy
  • Canada
  • India
  • China
  • Taiwan
  • Mexico
  • Perú
  • Russia
  • Chile
  • Argentina
  • Turkey
  • USA
  • +1(305)501-4948 Request Information
  • +1(305)501-4948 Request Information
IGENOMIX – With science on your sideIGENOMIX – With science on your side
  • Education
    • Fertility
  • Services for health specialists
    • ERA
    • EndomeTRIO
    • EMMA
    • ALICE
    • COVID-19 PCR
    • PGT-A + ERA Synchrony
    • PGT-A
    • Family Balancing
    • EMBRACE
    • PGT-M
    • SAT
    • POC
    • Oncodona
  • Services for patients
    • ERA
    • EndomeTRIO
    • EMMA
    • ALICE
    • PGT-A + ERA Synchrony
    • PGT-A
    • Family Balancing
    • Embrace
    • PGT-M
    • SAT
    • POC
    • Oncodona
  • About us
    • Research & Igenomix Foundation
    • About Igenomix
  • Blog
    • Fertility Challenges
    • Patient Stories
  • WEBINARS

ERA®

Endometrial Receptivity Analysis
NEW WEBINAR!

Understanding Endometrial Receptivity

Sign up

TIFFANY STANKEWICZ
SCIENTIFIC ADVISOR AND ERA SPECIALIST

TIFFANY STANKEWICZ
SCIENTIFIC ADVISOR AND ERA SPECIALIST

ERA®

Endometrial Receptivity Analysis
NEW WEBINAR!

Understanding Endometrial Receptivity

Sign up

ERA®

Endometrial Receptivity Analysis

Maximize your chances of pregnancy without losing good embryos

Request information

ERA®

Endometrial Receptivity Analysis

Indicated for all patients starting assisted reproductive treatments

Request information

ERA®

Endometrial Receptivity Analysis

7 in 10 women gave birth after 1 year*

Request information
Our Services > ERA

7 in 10 women gave birth after 1 year*

3 in every 10 women have a displaced window of implantation**

72.5%* pregnancy rate using ERA® in the first IVF cycle in any patient

Even the best embryo will fail to implant if conditions aren’t right

Overview

What is ERA® test?

  • ERA® is the first diagnostic test that determines each woman’s unique personalized embryo transfer timing, therefore synchronizing the embryo transfer with the individualized window of implantation.

Why choose ERA® by Igenomix?

 
ERA® is the most endorsed diagnostic test available, backed by 24 publications.

 

 

ERA® analyzes 248 genes, much more than any other tests in the market.

 

 
More +150,000 tests performed

 

Women who had their baby after one year*

Learn more about the ERA® test

Features

  • Benefits
  • Indications
  • FAQ's

Why use ERA?

  • When performing the embryo transfer in a personalized way, the chances of getting pregnant are increased after the assisted reproduction treatment.
  • 72.5%* pregnancy rate using ERA in the first IVF cycle in any patient.
  • Maximize your chances of pregnancy and don’t lose good embryos.
  • 7 in 10 women gave birth after 1 year*.
  • Our recent randomized study* proves that a personalized embryo transfer is superior to the classic frozen embryo transfer.

Is ERA for you?

This test is recommended if:

  • Indicated for all patients starting assisted reproductive treatments, and has the greatest benefit for those who have experienced repeated implantation failures.

Frequently asked questions about ERA ®

I'm interested in the ERA® test, where do I start?

Is there any chance I would need to repeat my ERA® test?

Is the ERA® test still helpful if I have been pregnant before?

What are the risks and limitations of the ERA® test?

My ERA® test result was abnormal

BROCHURE

Download

How does it work?

Request information

ERA test results

  • A RECEPTIVE RESULT

    A receptive result shows that the window of implantation is located on the day of taking the sample. The recommendation is to proceed with embryo transfer under the same conditions as for biopsy.

  • A NON-RECEPTIVE RESULT

    A non-receptive result shows a displaced window of implantation. In this case, with the ERA computational predictor, we will estimate your window of implantation indicating when your personalized embryo transfer is optimal in 90% of the cases. A second biopsy will be needed in only 10% of cases.

Scientific evidences

*Simón et al. A 5-year Multicenter Randomized Controlled Trial of In Vitro Fertilization with Personalized Blastocyst Transfer versus Frozen or Fresh Transfer. Reproductive BioMedicine Online (2020). DOI:10.1016/j.rbmo.2020.06.002

**In patients with recurrent implantation failure (RIF). Ruiz-Alonso et al., The endometrial receptivity array for diagnosis and personalized embryo transfer as a treatment for patients with repeated implantation failure. Fertility and Sterility, 2013;100(3):818-24. 10.1016/j.fertnstert.2013.05.004.

Request information about ERA®

  • reCAPTCHA demo: Simple page

Download our ebook

  • reCAPTCHA demo: Simple page

Download our ebook


  • reCAPTCHA demo: Simple page <

New Webinar!

Understanding Endometrial Receptivity

TIFFANY STANKEWICZ
SCIENTIFIC ADVISOR AND ERA SPECIALIST

Sign up

Save the date

THURSDAY, JANUARY 7, 2021

FAQ's

ALYSSA SNIDER
DIRECTOR OF GENETIC COUNSELING AT IGENOMIX USA

Know more

Request information about ERA®

  • reCAPTCHA demo: Simple page

Download our ebook

  • reCAPTCHA demo: Simple page

Download our ebook

  • reCAPTCHA demo: Simple page <

New Webinar!

Understanding Endometrial Receptivity

TIFFANY STANKEWICZ
SCIENTIFIC ADVISOR AND ERA SPECIALIST

Sign up

Save the date

THURSDAY, JANUARY 7, 2021

FAQ's

ALYSSA SNIDER
DIRECTOR OF GENETIC COUNSELING AT IGENOMIX USA

Know more

Request information about ERA®

  • <


  • reCAPTCHA demo: Simple page

Other services

EMMA

COMING SOON

More information

ALICE

COMING SOON

More information

EndomeTRIO

COMING SOON

More information

Request information about ERA®

  • reCAPTCHA demo: Simple page


Igenomix is in the media

Igenomix is not affiliated with any news outlet or publication identified above. News coverage does not constitute an endorsement of Igenomix or its products.

WE GUIDE YOU

Fertility
COVID-19 basic Q&A

 

OUR SERVICES

For Health Specialists
For Patients

ABOUT US

About Igenomix
Contact
Press and news
Work with us
Quality

FOLLOW IGENOMIX

Blog: Road to fertility

*CAP accreditation applies to the LA lab.

  +1 (305) 501-4948 
  Email us
  • Spain
  • United Kingdom
  • Europe
  • United States
  • Japan
  • The Middle East
  • Brazil
  • Italy
  • Canada
  • India
  • China
  • Taiwan
  • Mexico
  • Perú
  • Russia
  • Chile
  • Argentina
  • Turkey
Language

[2019] © Igenomix Privacy policy & cookies policy Quality policy Terms & conditions User Feedback

Help us to improve

  • *

Request Information


  • reCAPTCHA demo: Simple page

  • Education
    • Fertility
  • Services for health specialists
    • ERA
    • EndomeTRIO
    • EMMA
    • ALICE
    • COVID-19 PCR
    • PGT-A + ERA Synchrony
    • PGT-A
    • Family Balancing
    • EMBRACE
    • PGT-M
    • SAT
    • POC
    • Oncodona
  • Services for patients
    • ERA
    • EndomeTRIO
    • EMMA
    • ALICE
    • PGT-A + ERA Synchrony
    • PGT-A
    • Family Balancing
    • Embrace
    • PGT-M
    • SAT
    • POC
    • Oncodona
  • About us
    • Research & Igenomix Foundation
    • About Igenomix
  • Blog
    • Fertility Challenges
    • Patient Stories
  • WEBINARS
  • USA